Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Provides injectable and oral plan categories
What to do if retatrutide has been left unrefrigerated: Do not use the product until you have sought guidance from the trial pharmacist or prescribing clinician Quarantine the product set it aside and do not administer it pending assessment Do not attempt to re-refrigerate and use a product that may have been significantly heat-exposed, as returning it to the refrigerator does not reverse degradation Contact your trial pharmacist, prescribing clinician, or trial coordinator promptly they will assess the excursion against the protocol and stability data held by the sponsor Document the excursion record the approximate temperature, duration of exposure, and storage conditions as accurately as possible
Retatrutide is still in clinical trials as of 2024
As of mid-2025, the FDA had received over 600 reports of adverse events associated with compounded semaglutide products
Peer-reviewed safety review
Retatrutide is not semaglutide
US$ 24.69
US$ 28.67
US$ 22.97
US$ 29.00
US$ 21.74
US$ 28.65
US$ 25.32
